Hydrogen-based molecular medicine · Since 2017
Unleashing the therapeutic power of hydrogen
Molecular hydrogen in three forms: gas, liquid and solid. Developed with clinical research at Taiwan’s leading medical centers.
TFDA-approved for hospital useClinical trials in medical centersGMP, SGS and JFRL tested200+ pharmacy locations
FDASGSGMPJFRLTFDASelectUSA 2026
A word from our founder
“My mission is to make hydrogen-based precision therapies accessible to patients worldwide.”
Benson WangFounder, HoHo Biotech · 20+ years in biomedical innovation, background in neurogenetics
We develop molecular hydrogen capsules as a clinical adjuvant, supporting immune balance and helping reduce drug side effects. Our partners include medical centers, regional hospitals, leading pharmacy chains, clinics and aesthetic practices.
Understanding molecular hydrogen
Aging is the body, slowly rusting
Every cell produces free radicals as it works. Over time they drive oxidation, inflammation and glycation, damaging cells and DNA throughout the body.
Mitochondria
As we age, mitochondria, the cell’s power plants, become less efficient and begin to malfunction.
Free radicals
Damaged mitochondria release reactive oxygen species that harm DNA and proteins, and are linked to many chronic conditions.
Molecular hydrogen
Hydrogen is a rising star in building a “rust-proof” body, supporting the body’s own antioxidant and DNA-repair processes.
36
International medical
journal publications
journal publications
200+
Pharmacy chain
locations in Taiwan
locations in Taiwan
30+
Hydrogen human trials
underway worldwide
underway worldwide
Top 8
SelectUSA 2026
Defense Tech
Defense Tech
HoHo Biotech named a global Top 8 in Defense Tech at SelectUSA 2026
Go deeper into the science behind HoHo with our hydrogen journal: clinical news, research and absorption pathways.
Our story
From coral calcium to clinical adjuvant
HoHo Biotech focuses on autoimmune disease, hydrogen-based molecular medicine and gut microenvironment research, working toward hydrogen as a trusted adjuvant in mainstream medicine.
- 2017
HoHo Biotech is founded.
- 2018
Develops the Hydrogen Capsule, built on a proprietary natural coral calcium material.
- 2020
Receives TFDA approval for prescription use in regional hospitals, based on clinical trial data.
- 2022
Approved for prescription use in medical centers.
- 2024
Launches the H2 Capsule in pharmacy chains across 200+ locations, and builds a Molecular Intelligence Engine using AI molecular simulation.
- 2025
Launches HydroChat, an AI assistant for personalized use, and sets Gut Engineering as its core strategy.
- 2026
Named a global Top 8 in Defense Tech at the SelectUSA Investment Summit.